Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [5292]

ASCO 2020: Targeted therapy pralsetinib achieves high response rates in advanced cancers with RET gene fusions

ASCO 2020: Targeted therapy pralsetinib achieves high response rates in advanced cancers with RET gene fusions

ASCO 2020: Researchers underscore efficacy of pembrolizumab plus axitinib in treating advanced renal cell carcinoma

ASCO 2020: Researchers underscore efficacy of pembrolizumab plus axitinib in treating advanced renal cell carcinoma

ASCO 2020: Combination therapy well-tolerated and highly effective for patients with IDH1-mutated AML

ASCO 2020: Combination therapy well-tolerated and highly effective for patients with IDH1-mutated AML

ASCO 2020: Pembrolizumab doubles time to disease progression in patients with advanced colorectal cancer with specific DNA mutations

ASCO 2020: Pembrolizumab doubles time to disease progression in patients with advanced colorectal cancer with...

Researchers shrink breast cancer tumours in mice with targeted therapy

Researchers shrink breast cancer tumours in mice with targeted therapy

Exploiting viruses to attack cancer cells

Exploiting viruses to attack cancer cells

Blocking tumour signals can hinder cancer's spread

Blocking tumour signals can hinder cancer's spread

Treatment shows promise in treating deadly brain cancer

Treatment shows promise in treating deadly brain cancer

New cancer immunotherapy targeting myeloid cells slows tumour growth

New cancer immunotherapy targeting myeloid cells slows tumour growth

Study reveals first evidence inherited genetics can drive cancer's spread

Study reveals first evidence inherited genetics can drive cancer's spread

More from ecancer